PL1670803T3 - Podstawione spirocykliczne laktamy i ich zastosowanie jako leków - Google Patents
Podstawione spirocykliczne laktamy i ich zastosowanie jako lekówInfo
- Publication number
- PL1670803T3 PL1670803T3 PL04765790T PL04765790T PL1670803T3 PL 1670803 T3 PL1670803 T3 PL 1670803T3 PL 04765790 T PL04765790 T PL 04765790T PL 04765790 T PL04765790 T PL 04765790T PL 1670803 T3 PL1670803 T3 PL 1670803T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceuticals
- certain substituted
- substituted spirocyclic
- spirocyclic lactams
- lactams
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 150000003951 lactams Chemical class 0.000 title 1
- QAYAMAFOQWTHOB-UHFFFAOYSA-N 2-(6-oxo-1,7-diazaspiro[4.4]nonan-7-yl)propanamide Chemical class O=C1N(C(C)C(N)=O)CCC11NCCC1 QAYAMAFOQWTHOB-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0323204.8A GB0323204D0 (en) | 2003-10-03 | 2003-10-03 | Organic compounds |
| EP04765790A EP1670803B1 (en) | 2003-10-03 | 2004-10-04 | Certain substituted spirocyclic lactams and use thereof as pharmaceuticals |
| PCT/EP2004/011054 WO2005035535A1 (en) | 2003-10-03 | 2004-10-04 | Certain substituted spirocyclic lactams and use thereof as pharmaceuticals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1670803T3 true PL1670803T3 (pl) | 2008-08-29 |
Family
ID=29415468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04765790T PL1670803T3 (pl) | 2003-10-03 | 2004-10-04 | Podstawione spirocykliczne laktamy i ich zastosowanie jako leków |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20070015781A1 (pl) |
| EP (1) | EP1670803B1 (pl) |
| JP (1) | JP4549350B2 (pl) |
| CN (1) | CN1863804B (pl) |
| AT (1) | ATE388954T1 (pl) |
| AU (1) | AU2004279553C1 (pl) |
| BR (1) | BRPI0415015A (pl) |
| CA (1) | CA2540249A1 (pl) |
| DE (1) | DE602004012426T2 (pl) |
| ES (1) | ES2300815T3 (pl) |
| GB (1) | GB0323204D0 (pl) |
| MX (1) | MXPA06003645A (pl) |
| PL (1) | PL1670803T3 (pl) |
| PT (1) | PT1670803E (pl) |
| WO (1) | WO2005035535A1 (pl) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20040762A1 (es) * | 2002-11-27 | 2004-11-06 | Elan Pharm Inc | Ureas substituidas y carbamatos utiles para el tratamiento de la enfermedad de alzheimer |
| CA2609562A1 (en) * | 2005-06-14 | 2006-12-28 | Schering Corporation | Macrocyclic heterocyclic aspartyl protease inhibitors |
| CA2615656A1 (en) * | 2005-07-18 | 2007-01-25 | Merck & Co., Inc. | Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| US7745484B2 (en) * | 2005-11-21 | 2010-06-29 | Amgen Inc. | Beta-secretase modulators and methods of use |
| MX2011003015A (es) | 2008-09-18 | 2011-11-18 | Univ Northwestern | Moduladores del receptor de n-metil-d-aspartato, y usos de los mismos. |
| GB201122113D0 (en) | 2011-12-22 | 2012-02-01 | Convergence Pharmaceuticals | Novel compounds |
| SG11201505937SA (en) | 2013-01-29 | 2015-09-29 | Naurex Inc | Spiro-lactam nmda receptor modulators and uses thereof |
| CN105308049A (zh) | 2013-01-29 | 2016-02-03 | 阿普廷伊克斯股份有限公司 | 螺-内酰胺nmda受体调节剂及其用途 |
| CA2898861C (en) | 2013-01-29 | 2021-07-20 | Naurex, Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| JP6419087B2 (ja) | 2013-01-29 | 2018-11-07 | アプティニックス インコーポレイテッド | スピロラクタム系nmda受容体モジュレーターおよびその使用 |
| WO2014120784A1 (en) | 2013-01-29 | 2014-08-07 | Naurex, Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| PE20190174A1 (es) | 2016-05-19 | 2019-02-01 | Aptinyx Inc | Moduladores del receptor espiro-lactama n-metil-d-aspartato y usos de los mismos |
| WO2017201285A1 (en) | 2016-05-19 | 2017-11-23 | Aptinyx Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| JP2019527235A (ja) | 2016-08-01 | 2019-09-26 | アプティニックス インコーポレイテッド | スピロ−ラクタム及びビス−スピロ−ラクタムnmda受容体修飾因子及びその使用 |
| CN109890825B (zh) | 2016-08-01 | 2022-03-11 | 阿普廷伊克斯股份有限公司 | 螺-内酰胺nmda受体调节剂及其用途 |
| PE20190501A1 (es) | 2016-08-01 | 2019-04-10 | Aptinyx Inc | Moduladores nmda espiro-lactam y metodos de uso de los mismos |
| CA3031534C (en) | 2016-08-01 | 2023-10-17 | Aptinyx Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| EP3490992B1 (en) | 2016-08-01 | 2023-03-22 | Aptinyx Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| PE20210455A1 (es) | 2018-01-31 | 2021-03-08 | Aptinyx Inc | Moduladores del receptor nmda espiro-lactama y usos de los mismos |
| BR112021026380A2 (pt) * | 2019-06-24 | 2022-05-10 | Naurex Inc | Formas sólidas de (s)-2-((2s,3r)-1-amino-3-hidróxi-1-oxobutan-2-il)-1-oxo-2,5-diazaespiro[3.4]octano-5-carboxilato de terc-butila e métodos de preparação das mesmas |
| US12012413B2 (en) | 2019-11-11 | 2024-06-18 | Tenacia Biotechnology (Hong Kong) Co., Limited | Methods of treating painful diabetic peripheral neuropathy |
| EP4608834A1 (en) * | 2022-10-26 | 2025-09-03 | Protego Biopharma, Inc. | Spirocycle containing pyridine compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5534520A (en) | 1990-04-10 | 1996-07-09 | Fisher; Abraham | Spiro compounds containing five-membered rings |
| ES2162503T3 (es) * | 1998-06-12 | 2001-12-16 | Hoffmann La Roche | Derivados diaza-espiro(3,5)nonanos. |
| US6613764B1 (en) * | 1999-01-06 | 2003-09-02 | The United States Of America As Represented By The Department Of Health And Human Services | Aspartic protease inhibitors |
| JP2004534017A (ja) * | 2001-04-27 | 2004-11-11 | バーテックス ファーマシューティカルズ インコーポレイテッド | Baceのインヒビター |
| CA2590750A1 (en) * | 2004-12-20 | 2006-06-29 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Myd88 homodimerization inhibitors |
-
2003
- 2003-10-03 GB GBGB0323204.8A patent/GB0323204D0/en not_active Ceased
-
2004
- 2004-10-04 US US10/574,536 patent/US20070015781A1/en not_active Abandoned
- 2004-10-04 WO PCT/EP2004/011054 patent/WO2005035535A1/en not_active Ceased
- 2004-10-04 AT AT04765790T patent/ATE388954T1/de not_active IP Right Cessation
- 2004-10-04 PT PT04765790T patent/PT1670803E/pt unknown
- 2004-10-04 MX MXPA06003645A patent/MXPA06003645A/es active IP Right Grant
- 2004-10-04 AU AU2004279553A patent/AU2004279553C1/en not_active Ceased
- 2004-10-04 BR BRPI0415015-5A patent/BRPI0415015A/pt not_active IP Right Cessation
- 2004-10-04 DE DE602004012426T patent/DE602004012426T2/de not_active Expired - Lifetime
- 2004-10-04 PL PL04765790T patent/PL1670803T3/pl unknown
- 2004-10-04 CA CA002540249A patent/CA2540249A1/en not_active Abandoned
- 2004-10-04 ES ES04765790T patent/ES2300815T3/es not_active Expired - Lifetime
- 2004-10-04 JP JP2006530082A patent/JP4549350B2/ja not_active Expired - Fee Related
- 2004-10-04 EP EP04765790A patent/EP1670803B1/en not_active Expired - Lifetime
- 2004-10-04 CN CN2004800288403A patent/CN1863804B/zh not_active Expired - Fee Related
-
2007
- 2007-06-26 US US11/823,311 patent/US7655686B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PT1670803E (pt) | 2008-04-23 |
| JP2007509038A (ja) | 2007-04-12 |
| EP1670803B1 (en) | 2008-03-12 |
| ES2300815T3 (es) | 2008-06-16 |
| BRPI0415015A (pt) | 2006-11-07 |
| US7655686B2 (en) | 2010-02-02 |
| MXPA06003645A (es) | 2006-06-05 |
| ATE388954T1 (de) | 2008-03-15 |
| US20070015781A1 (en) | 2007-01-18 |
| CA2540249A1 (en) | 2005-04-21 |
| CN1863804A (zh) | 2006-11-15 |
| DE602004012426T2 (de) | 2009-03-26 |
| AU2004279553B2 (en) | 2009-03-12 |
| GB0323204D0 (en) | 2003-11-05 |
| AU2004279553A1 (en) | 2005-04-21 |
| CN1863804B (zh) | 2010-05-26 |
| WO2005035535A1 (en) | 2005-04-21 |
| DE602004012426D1 (de) | 2008-04-24 |
| JP4549350B2 (ja) | 2010-09-22 |
| HK1092472A1 (en) | 2007-02-09 |
| AU2004279553C1 (en) | 2009-07-23 |
| US20070265328A1 (en) | 2007-11-15 |
| EP1670803A1 (en) | 2006-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1670803E (pt) | Certas lactamas espirocíclicas substituídas e a sua utilização como produtos farmacêuticos | |
| MXPA05010137A (es) | Derivados de tetrahidroisoquinolil acetamida para usarse como antagonistas del receptor de orexina. | |
| MY140693A (en) | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
| AU2002319814A1 (en) | Substituted 1h-dihydropyrazoles, their preparation and use | |
| MY136520A (en) | Novel compounds | |
| WO2005123731A3 (en) | Pyrrolopyridine derivatives and their use as crth2 antagonists | |
| WO2006034039A3 (en) | Substituted morphinans and methods of their use | |
| TW200833670A (en) | Novel compounds 569 | |
| TW200503710A (en) | Novel compounds | |
| WO2005040171A8 (en) | Pyrazolo and imidazo-pyrimidine derivatives | |
| NO20063355L (no) | Nye trisykliske spiroderivater som modulatorer for kemokinreseptoraktivitet | |
| MXPA05004273A (es) | Derivados de fenilalquil y piridilalquil piperazina. | |
| SI1673354T1 (sl) | Arilindenopiridini in arilindenopirimidini in njihova uporaba kot antagonisti adenozinskih A2a-receptorjev | |
| TW200626581A (en) | Compounds, compositions containing them, preparation thereof and uses thereof | |
| WO2005000840A8 (en) | Substituted diketopiperazines and their use as oxytocin antagonists | |
| TW200504059A (en) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof | |
| SI1730144T1 (sl) | Substituirane spojine 1,4,8-triazaspiro(4.5)dekan-2-on | |
| MXPA05011163A (es) | Derivados de 3-benzhidriliden-8-azabiciclo[3.2.1]octano con actividad de receptores opioides. | |
| TW200740781A (en) | Novel compounds | |
| MXPA02012426A (es) | Compuestos nuevos. | |
| WO2003045940A3 (en) | Benzazepine derivatives and their use as 5-ht ligands | |
| BG106893A (en) | NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM | |
| MXPA05005340A (es) | Nuevos derivados antagonistas del receptor de la vitronectina, sus procedimientos de preparacion, su aplicacion como medicamentos y los compuestos farmaceuticos que los contienen. | |
| ATE345343T1 (de) | Triazolo(4,5-d)pyrimidinderivate als antithrombotische verbindungen | |
| TW200500356A (en) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |